Merck Launches Tender Offer To Acquire Terns Pharmaceuticals
(RTTNews) - Merck & Co Inc. (MRK) said Tuesday it has commenced a cash tender offer to acquire all outstanding shares of Terns Pharmaceuticals, Inc. (TERN).
The move follows a definitive agreement announced on March 25, 2026, under which Merck agreed to acquire Terns.
Under the terms of the tender offer, Terns shareholders will receive $53 per share in cash upon closing.
Following completion of the offer, Terns will become a unit of Merck.
The tender offer is set to expire on May 4, and the transaction is expected to close in the second quarter of 2026.
Terns Pharma shares closed at $52.78 on Monday, up 0.11%.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.